Kymera Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
I'm Brian Abrams, Senior Biotech Analyst at RBC Capital Markets. Really pleased to have our next featured company, Kymera Therapeutics, represented by their CMO and CFO, Jared Golub, and Bruce Jacobs. So thank you guys so much for being here.
Thanks for having us, Brian.
Questions & Answers
I want to start on STAT6, but I know there's a lot to cover and the pipeline is continuing to expand, but maybe just starting with KT-621.You're now several months into enrollment for the Phase 2b atopic dermatitis study. Can you talk a little bit more about, really, I guess, bigger picture of how that's all going?
You can touch on the pace and quality of enrollment at a high level, the overall enthusiasm you're seeing from the populations of interest, such as adolescents, and just, I guess, your sense as to any initial learnings and takeaways as that's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
